Your browser doesn't support javascript.
loading
Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning.
Kim, Yoonji; Lee, Hansaem; Park, Keunwan; Park, Sora; Lim, Ju-Hyeon; So, Min Kyung; Woo, Hye-Min; Ko, Hyemin; Lee, Jeong-Min; Lim, Sun Hee; Ko, Byoung Joon; Park, Yeon-Su; Choi, So-Young; Song, Du Hyun; Lee, Joo-Yeon; Kim, Sung Soon; Kim, Dae Young.
Afiliación
  • Kim Y; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do 28160, Korea.
  • Lee H; Korea Center for Disease Control, Osong Health Technology Administration Complex, Cheongju-si, Chungcheongbuk-do 28159, Korea.
  • Park K; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do 28160, Korea.
  • Park S; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do 28160, Korea.
  • Lim JH; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do 28160, Korea.
  • So MK; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do 28160, Korea.
  • Woo HM; Korea Center for Disease Control, Osong Health Technology Administration Complex, Cheongju-si, Chungcheongbuk-do 28159, Korea.
  • Ko H; Korea Center for Disease Control, Osong Health Technology Administration Complex, Cheongju-si, Chungcheongbuk-do 28159, Korea.
  • Lee JM; Plexense, Inc., Yongin-si, Gyeonggi-do 441-813, Korea.
  • Lim SH; Plexense, Inc., Yongin-si, Gyeonggi-do 441-813, Korea.
  • Ko BJ; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do 28160, Korea.
  • Park YS; Plexense, Inc., Yongin-si, Gyeonggi-do 441-813, Korea.
  • Choi SY; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do 28160, Korea.
  • Song DH; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do 28160, Korea.
  • Lee JY; Korea Center for Disease Control, Osong Health Technology Administration Complex, Cheongju-si, Chungcheongbuk-do 28159, Korea.
  • Kim SS; Korea Center for Disease Control, Osong Health Technology Administration Complex, Cheongju-si, Chungcheongbuk-do 28159, Korea.
  • Kim DY; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do 28160, Korea. kimdae@kbiohealth.kr.
Antibodies (Basel) ; 8(3)2019 Jul 31.
Article en En | MEDLINE | ID: mdl-31544848
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Antibodies (Basel) Año: 2019 Tipo del documento: Article Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Antibodies (Basel) Año: 2019 Tipo del documento: Article Pais de publicación: Suiza